{
  "docId": "019de513-bbaf-7632-8c51-2e65d00dc762",
  "docSlug": "d61504792622527e2ff1c803565a1f5e",
  "documentTitle": "Bausch+Lomb | Results Presentation Deck | 42 slides",
  "authorId": "bausch-lomb",
  "authorName": "Bausch + Lomb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 15,
  "pageCount": 42,
  "prevPage": 14,
  "nextPage": 16,
  "slideType": "propose_solution",
  "function": "propose_solution",
  "density": "dense",
  "nDataPoints": 10,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de513-bbaf-7632-8c51-2e65d00dc762/15",
  "deckHref": "/decks/019de513-bbaf-7632-8c51-2e65d00dc762",
  "deckJsonHref": "/decks/019de513-bbaf-7632-8c51-2e65d00dc762.json",
  "deckAnchorHref": "/decks/019de513-bbaf-7632-8c51-2e65d00dc762#slide-15",
  "components": [
    {
      "bbox": {
        "h": 0.64,
        "w": 0.43,
        "x": 0.047,
        "y": 0.18
      },
      "kind": "chart",
      "text": "Successful +$100M Brand Expanding...\n% of Weekly Market Share in Redness Reliever Category¹\nLumify 47%\nClear Eyes 23%\nPrivate Label 12%\nRohto 8%\nVisine 7%\nAll Other 4%",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f96955fa-ef6e-4d6e-8abd-0a6590a66249",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.64,
        "w": 0.409,
        "x": 0.543,
        "y": 0.18
      },
      "kind": "list",
      "text": "...Geographically and Through Planned Line Extensions²\nLaunched in U.S., Canada and South Korea\nExpect to launch LUMIFY® in several international markets in 2022 and beyond\nLumify® Eye Illuminations\nSpecialty eye care line scientifically developed for the sensitive eye area to help enhance eyes' natural beauty\nLumify® Preservative Free (Single Dose)\nCombination product with ketotifen for allergy symptom control",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1e780789-a9b2-4358-81f4-8344b7475f36",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.402,
        "x": 0.156,
        "y": 0.948
      },
      "kind": "source-note",
      "text": "1. IRI Panel Omnichannel; trademarks are property of respective owners.\n2. See slide 1 for further information on forward-looking statements.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "36add6d5-885d-4cd4-ae56-361e62f1b476",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.079,
        "w": 0.909,
        "x": 0.047,
        "y": 0.04
      },
      "kind": "title",
      "text": "Creating a Lumify® Franchise Uniquely Positioned with Bausch + Lomb's Integrated Platform",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "99a08ae2-c946-4efb-967b-93905770c5b1",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "2x2 matrix",
      "slug": "matrix-2x2",
      "agent": null,
      "layer": "slide",
      "matchId": "b8e8c969-03d4-40dc-a198-517dde68f67b",
      "evidence": "% of Weekly Market Share in Redness Reliever Category¹",
      "confidence": 0.5
    },
    {
      "name": "AIDA Model",
      "slug": "aida-model",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "47d10fb2-a4cf-4d45-8c7b-6be744ab3a3f",
      "evidence": "Creating a Lumify® Franchise Uniquely Positioned with Bausch + Lomb's Integrated Platform",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 21,
      "from": 15,
      "beatId": "9866f7a1-7d5c-4813-8b8a-f1268197141e",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "Slides 15-21 propose solutions and highlight the company's portfolio and strategic agreements",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 15,
      "from": 6,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "d0820f93-74dc-4006-a0cc-2e2499a07167",
      "evidence": "The loop opens on slide 6 and closes on slide 15, showcasing the company's opportunities",
      "position": 0,
      "objective": "Highlighting the benefits of a standalone Bausch + Lomb",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}